Projected Price to Earnings: Novanta Corp (NOVT)

NOVT (Novanta Inc.) - company brandmark

The balanced structure of Novanta Inc. high-tech instrumentation serves as the primary growth driver, which is confirmed by the company's forward P/E ratio, currently standing at 27.60. Business stability relies on the supply of precision sensors and lasers. Diversification through the development of 3D printing and robotics systems mitigates risks. The model's efficiency depends on R&D breakthroughs and the share of recurring payments for consumables.

novanta.com - NOVT Market Cap to Future Earnings Ratio (period 07/04/2022 - 11/14/2026)

Metric breakdowns and analytics for Novanta Photonics (NOVT)

- stock quotes and analyst forecast:
- company stock exchange capitalization indicators:
Fundamental valuation:NOVT Novanta
Brand item of novanta.com

The digitalization of logistics hubs and the production of precision components for robotics by Novanta Inc. create a foundation for long-term operating profit growth. Reflecting the relationship between the current share price and projected earnings per share, the business's forward P/E demonstrates market expectations for the capitalization of these technological advantages, where low values indicate undervalued assets and sharp peaks signal overvaluation.

Competitors of Novanta Inc.

Forward P/E Multiple DXCM|PEN - Projected Price to Earnings Ratio|Haemonetics Corp. - Projected Price to Earnings|Forward P/E Multiple Inspire Medical Systems Inc INSP|PRCT: Projected Price to Earnings|conmed.com - Market Cap to Future Earnings Ratio|PLSE: Forward P/E Multiple|INMD - Market Cap to Projected Earnings|PMI (Picard Medical Inc.) - Forward P/E Multiple|Projected Price to Earnings Surmodics Inc. (SRDX)|Projected Price to Earnings SENS (Senseonics)|NPCE (neuropace.com) - Future Price to Earnings Multiple|Future Price to Earnings Tactile Medical TCMD|SNWV - Projected Price to Earnings|Outset - Forward P/E Multiple|Projected Price to Earnings Ratio Electromed, Inc.|LNSR: Forward P/E Multiple|Price to Future Earnings Ratio RCEL|PROF (Profound Medical Corp) - Forward P/E Multiple|Baird Medical Corp (BDMD) - Market Cap to Projected Earnings|Forward P/E Multiple EDAP|Projected Price to Earnings apyxmedical.com APYX|Forward P/E Multiple ICCM (IceCure Medical)|Forward P/E Multiple Pulmonx Corp LUNG|TELA - Future Price to Earnings|CTSO: Future Price to Earnings|SRTS (Sensus Healthcare Corp) - Projected Price to Earnings|Zynex Corp - Future Price to Earnings Multiple|ECOR (electroCore Inc) - Forward P/E Multiple|Projected Price to Earnings Ratio Vicarious Surgical Corp RBOT|Future Price to Earnings Inspira Technologies Oxy (IINN)|SeaStar Medical Holding Corporation (ICU) - Forward Price to Earnings Multiple|IRIDEX - Projected Price to Earnings|Forward P/E Multiple Intelligent Bio Solutions Inc INBS|AINostix - Forward P/E Multiple|Market Cap to Projected Earnings profusa.com PFSA|strataskinsciences.com (SSKN) - Future Price to Earnings|Price to Expected Earnings Ratio GCTK (glucotrack.com)|Future Price to Earnings NanoVibronix|Projected Price to Earnings Venus Concept Corporation (VERO)|Forward P/E Multiple NUWE|AEMD - Projected Price to Earnings Ratio|Future Price to Earnings Asensus Surgical ASXC|AVGR: Price to Future Earnings Ratio|BSGM: Projected Price to Earnings|Cutera Inc - Market Cap to Future Earnings Ratio|Know Labs, Inc. (KNW) - Future Price to Earnings|Price to Future Earnings Ratio NARI|Future Price to Earnings Nevro|Projected Price to Earnings Ratio ReShape Lifesciences Inc RSLS|Projected Price to Earnings SILK (Silk Road Medical Inc.)